Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis

Stopped early · Phase 2

Conditions studied: Cystitis, Interstitial

In brief

This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis

Key facts

Study ID

NCT00380783

Run by

Allergan

People needed

2

Starts

2006-10-01

Expected to finish

2007-03-01

Last updated by the study team

2011-05-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of painful bladder syndrome/interstitial cystitis
• Moderate or severe bladder pain

You may not qualify if…

• Any other uncontrolled disease
• Pregnant or nursing females

Where it is running

• Study site — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.